We evaluated the differences in TCR richness and BCR richness between the high-risk and low-risk groups and found that the high-risk group had significantly higher TCR abundance and BCR richness than the low-risk group, which reflected greater functionality of T cells and B cells in recognizing antigens and killing tumor cells in high-risk HCC patients. The gene discussed is BCR; the disease is neoplasm.